Shulman, N. Danny

N. Danny Shulman

Associate

n.danny.shulman@lw.com
    Shulman, N. Danny

    N. Danny Shulman

    Associate

    n.danny.shulman@lw.com

    Profile

    N. Danny Shulman is an associate in the New York office of Latham & Watkins.

    Mr. Shulman primarily handles capital markets transactions and public company representation, including representing issuers, underwriters, agents, and initial purchasers in initial and follow-on public equity offerings, ATM programs, and secured and unsecured high yield debt offerings.

    Experience

    Mr. Shulman’s experience includes representing: 

    • Sight Sciences
    • SQZ Biotechnologies
    • Atea Pharmaceuticals
    • Allegro MicroSystems
    • Frequency Therapeutics
    • MeiraGTx
    • BioXcel Therapeutics
    • Eloxx Pharmaceuticals
    • ContraFect Corporation
    • T2Biosystems
    • Underwriters and sales agents in equity offerings by Axcella Health, Addus Homecare, AdaptHealth, Clearway, Nanox
      Imaging, scPharmaceuticals, and Tecnoglass 
    • Initial Purchasers in unsecured and unsecured notes offerings, including green bonds and sustainability linked notes, by leading energy companies

    Qualifications

    Bar Qualification

    • New Jersey
    • New York
    • Pennsylvania

    Education

    • JD, University of Pennsylvania Law School, 2016
      Law Review, Wharton Certificate in Business Economics and Public Policy
    • BA, BS in Jewish Philosophy & Accounting, Yeshiva University, 2012
      summa cum laude

    Practices

    Industries

    News & Insights

    Read More